GeoVax raises ~$5.0M in registered direct offering at $5.125/share with warrants

GeoVax Labs, Inc.

Offering of 837,500 common shares at $5.125/share and 138,110 pre-funded warrants at $5.12499, exercise price $0.0001.
Concurrent private placement issued 975,610 common warrants at $5.00/share, exercisable immediately, 5-year term.
Gross proceeds ~$5.0M; net proceeds ~$4.6M after placement agent fees and expenses.
Roth Capital Partners served as exclusive placement agent; offering closed August 30, 2024.
Proceeds to be used for working capital and general corporate purposes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.